Welcome to the IKCEST

Research Square | Vol., Issue. | 2020-07-14 | Pages

Research Square

Development and validation of a CT radiomics signature for diagnosing COVID-19 pneumonia compared with CO-RADS

Liu, Huanhuan   Hou, Liang   Zhang, Shuhai   Li, Huimin   Wang, Dengbin   Chi, Runmin   Chen, Yanhong   Duan, Shaofeng   Xie, Zongyu   Li, Jinning   Xu, He   Wu, Zengbin   Zheng, Hui   Ren, Hua  
Abstract

Objectives: To develop and validate a CT radiomics signature for diagnosing COVID-19 pneumonia compared with clinical model and COVID-19 reporting and data system (CO-RADS).

Methods: This two-center retrospective study enrolled 115 laboratory-confirmed COVID-19 patients with 1127 lesions and 435 non-COVID-19 pneumonia patients with 842 lesions. In study 1, a radiomics signature and a clinical model was developed and validated in the training and internal validation cohorts (patient/lesion [n] = 379/1325, n = 131/505) for identifying COVID-19 pneumonia. In study 2, the developed radiomics signature was tested in another independent cohort including all viral pneumonia (n = 40/139), compared with clinical model and CO-RADS approach. The predictive performance was assessed by receiver operating characteristics curve (ROC) analysis, calibration curve, and decision curve analysis (DCA).

Results: Twenty-three texture features were selected to construct the radiomics model. Radiomics model outperformed the clinical model in diagnosing COVID-19 pneumonia with an area under the ROC (AUC) of 0.98 and good calibration in the internal validation cohort. Radiomics model also performed better in the testing cohort to distinguish COVID-19 from other viral pneumonia with an AUC of 0.96 compared with 0.75 (P=0.007) for clinical model, and 0.69 (P=0.002) or 0.82 (P=0.04) for two trained radiologists using CO-RADS approach. The sensitivity and specificity of radiomics model can be improved to 0.90 and 1.00. The DCA confirmed the clinical utility of radiomics model. 

Conclusions: The proposed radiomics signature outperformed clinical model and CO-RADS approach for diagnosing COVID-19, which can facilitate rapid and accurate detection of COVID-19 pneumonia.

Original Text (This is the original text for your reference.)

Development and validation of a CT radiomics signature for diagnosing COVID-19 pneumonia compared with CO-RADS

Objectives: To develop and validate a CT radiomics signature for diagnosing COVID-19 pneumonia compared with clinical model and COVID-19 reporting and data system (CO-RADS).

Methods: This two-center retrospective study enrolled 115 laboratory-confirmed COVID-19 patients with 1127 lesions and 435 non-COVID-19 pneumonia patients with 842 lesions. In study 1, a radiomics signature and a clinical model was developed and validated in the training and internal validation cohorts (patient/lesion [n] = 379/1325, n = 131/505) for identifying COVID-19 pneumonia. In study 2, the developed radiomics signature was tested in another independent cohort including all viral pneumonia (n = 40/139), compared with clinical model and CO-RADS approach. The predictive performance was assessed by receiver operating characteristics curve (ROC) analysis, calibration curve, and decision curve analysis (DCA).

Results: Twenty-three texture features were selected to construct the radiomics model. Radiomics model outperformed the clinical model in diagnosing COVID-19 pneumonia with an area under the ROC (AUC) of 0.98 and good calibration in the internal validation cohort. Radiomics model also performed better in the testing cohort to distinguish COVID-19 from other viral pneumonia with an AUC of 0.96 compared with 0.75 (P=0.007) for clinical model, and 0.69 (P=0.002) or 0.82 (P=0.04) for two trained radiologists using CO-RADS approach. The sensitivity and specificity of radiomics model can be improved to 0.90 and 1.00. The DCA confirmed the clinical utility of radiomics model. 

Conclusions: The proposed radiomics signature outperformed clinical model and CO-RADS approach for diagnosing COVID-19, which can facilitate rapid and accurate detection of COVID-19 pneumonia.

+More

Cite this article
APA

APA

MLA

Chicago

Liu, Huanhuan, Hou, Liang, Zhang, Shuhai, Li, Huimin, Wang, Dengbin, Chi, Runmin, Chen, Yanhong, Duan, Shaofeng, Xie, Zongyu, Li, Jinning, Xu, He, Wu, Zengbin, Zheng, Hui, Ren, Hua,.Development and validation of a CT radiomics signature for diagnosing COVID-19 pneumonia compared with CO-RADS. (),.

Disclaimer: The translated content is provided by third-party translation service providers, and IKCEST shall not assume any responsibility for the accuracy and legality of the content.
Translate engine
Article's language
English
中文
Pусск
Français
Español
العربية
Português
Kikongo
Dutch
kiswahili
هَوُسَ
IsiZulu
Action
Recommended articles

Report

Select your report category*



Reason*



By pressing send, your feedback will be used to improve IKCEST. Your privacy will be protected.

Submit
Cancel